Granite Investment Partners, LLC Collegium Pharmaceutical, Inc Transaction History

Granite Investment Partners, LLC

  • $2.26 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 13, 2019
SELL
$13.58 - $18.72 $523,943 - $722,255
-38,582 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$14.78 - $19.68 $199,042 - $265,030
13,467 Added 53.62%
38,582 $663,000
Q1 2018

May 04, 2018
SELL
$18.15 - $29.21 $813,210 - $1.31 Million
-44,805 Reduced 64.08%
25,115 $642,000
Q4 2017

Feb 01, 2018
BUY
$9.3 - $19.14 $165,391 - $340,385
17,784 Added 34.11%
69,920 $1.29 Million
Q3 2017

Nov 08, 2017
BUY
$9.15 - $11.97 $477,044 - $624,067
52,136
52,136 $547,000

Others Institutions Holding COLL

# of Institutions
249
Shares Held
36.2M
Call Options Held
100K
Put Options Held
21.1K
View Full List

About COLLEGIUM PHARMACEUTICAL, INC

COLL Quotes by TradingView
  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.11B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email